.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
US Department of Justice
Teva
Mallinckrodt
Farmers Insurance
UBS
Medtronic
Covington
Fuji
Chinese Patent Office

Generated: July 28, 2017

DrugPatentWatch Database Preview

AMIODARONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Amiodarone Hydrochloride, and what generic Amiodarone Hydrochloride alternatives are available?

Amiodarone Hydrochloride is a drug marketed by Hospira, Wockhardt, Sandoz, Mylan Institutional, Bedford, Taro Pharm, Zydus Pharms Usa Inc, Akorn, Hikma Farmaceutica, Teva Pharms, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Teva Pharms Usa, Murty Pharms, Apotex Inc, Hospira Inc, Ben Venue, Mylan, Mayne Pharma Inc, Intl Medication Sys, Par Sterile Products, Teva, and Bedford Labs. and is included in twenty-eight NDAs.

The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.

Summary for Tradename: AMIODARONE HYDROCHLORIDE

Patents:0
Applicants:24
NDAs:28
Suppliers / Packagers: see list33
Bulk Api Vendors: see list49
Clinical Trials: see list2,338
Patent Applications: see list541
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMIODARONE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET;ORAL074895-001Apr 16, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET;ORAL075188-001Feb 24, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford Labs
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE;INJECTION076299-001Oct 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma Inc
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET;ORAL075389-001Jan 25, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE;INJECTION076108-001Oct 15, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Federal Trade Commission
US Army
Moodys
Medtronic
Chubb
McKesson
Novartis
Healthtrust
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot